These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10555884)

  • 1. Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate.
    Cantatore FP; Acquista CA; Pipitone V
    J Rheumatol; 1999 Nov; 26(11):2318-23. PubMed ID: 10555884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.
    Gough A; Sambrook P; Devlin J; Huissoon A; Njeh C; Robbins S; Nguyen T; Emery P
    J Rheumatol; 1998 Jul; 25(7):1282-9. PubMed ID: 9676757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
    Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
    Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
    Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Feb; 27(2):324-31. PubMed ID: 10685792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis.
    Matsuzaki T; Nakajima A; Ishigami S; Tanno M; Yoshino S
    Rheumatology (Oxford); 2006 Feb; 45(2):182-6. PubMed ID: 16319105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
    Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A
    Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis.
    Hasegawa J; Nagashima M; Yamamoto M; Nishijima T; Katsumata S; Yoshino S
    J Rheumatol; 2003 Mar; 30(3):474-9. PubMed ID: 12610804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
    Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.
    Cantatore FP; Loperfido MC; Mancini L; Carrozzo M
    J Rheumatol; 1992 Nov; 19(11):1753-5. PubMed ID: 1491396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
    Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Lioté F; Debiais F; Juvin R; Le Goff P; Masson C
    J Rheumatol; 1998 Aug; 25(8):1457-61. PubMed ID: 9712083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
    Fröde TS; Tenconi P; Debiasi MR; Medeiros YS
    Mediators Inflamm; 2002 Dec; 11(6):345-9. PubMed ID: 12581498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
    Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.